PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
LTS Expands CDMO Portfolio with Ophthalmic Drug Delivery Solutions
2026-04-29T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical Equipment 
ESG | HitGen Releases 2025 Sustainability Report
2026-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
European Commission (EC) Approves Henlius and Organon's POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
2026-04-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial Results
2026-04-29T    Biotechnology   Health Care/Hospital 
Piramal Pharma Limited Announces Results for Q4 and Full-year FY26
2026-04-29T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Natural Field Releases Research Findings on NFTriSolve® Co-Loading Liposome Formula
2026-04-28T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Fosun Pharma Announces Q1 2026 Results: Net Profit Attributable to Shareholders After Deducting Non-Recurring Gains and Losses Increased by 21.96% YoY, With Strong Pipeline Execution
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)
2026-04-28T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.